CLINICAL_TRIALS
trial_result
· 2012-10-26
Clinical Trial Update: Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED) [Phase 1]
Summary
Phase I study of MK-1496 in patients with advanced solid tumors has been completed, and the results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Neoplasms, Malignant | Phase 1 | Status: COMPLETED | Results posted: 2012-10-26